Search results
Results From The WOW.Com Content Network
In this article we presented the 10 medical technology stocks to buy. You can skip our detailed discussion on these stocks, and read the 5 Medical Technology Stocks to Buy. The unprecedented COVID ...
Medical Information Technology, Inc., shortened to Meditech, is a privately held Massachusetts-based software and service company that develops and sells information ...
AdvaMed, or the Advanced Medical Technology Association, is an American medical device trade association, based in Washington, D.C. It is the largest medical device association in the world [1] with U.S. and international members who are medical technology companies (medical devices, diagnostic products, and health information systems) that collectively represents 80% of U.S. medical ...
Medical Properties Trust (NYSE: MPW) is a prime example of a high-risk, high-reward stock. In just the past three years, the stock price for this real estate investment trust (REIT) has fallen 77%.
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences.The company was formerly organised in three business areas: Infection Control (trading as Getinge), Extended Care (ArjoHuntleigh) and Medical Systems (Maquet, the world's largest maker of surgical tables), but announced it would become a single ...
With a high forward dividend yield of 7.4%, Medical Properties Trust (NYSE: MPW) is of natural interest to investors seeking an income stream in their portfolios. Its business model, if executed ...
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. [2] Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as ...
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug ...